MILPITAS, Calif. -
Oct. 16, 2019 -
PRLog -- Cyclic adenosine-3',5'-
monophosphate (cyclic AMP or cAMP) is a vital second messenger molecule in eukaryotes as well as a relevant signaling effector in bacteria. Intracellular cAMP-mediated signaling cascades control many biological pathways such as glucose and lipid metabolism via activation of protein kinase A and cyclic nucleotide gated ion channels. Intracellular cAMP is synthesized from ATP by the enzyme adenylyl cyclase and is inactivated by hydrolytic cyclic-AMP phosphodiesterase enzymes (cPDEs; EC 3.1.4.53). Inhibition of cPDEs has been shown to impact many biological pathways including cognition, neuronal signaling, inflammation and vascular smooth muscle contractility. Eleven superfamilies of PDEs with varying selectivity for cAMP or other cyclic nucleotides have been identified in mammals. The predominant phosphodiesterase isoforms involved in the degradation of cAMP are phosphodiesterase 4 (PDE4) family members. There are many unique isoforms of the enzyme, expressed either as products of different genes or through alternative splicing, and their expression levels are cell-type dependent. BioVision's cAMP Phosphodiesterase Activity Assay Kit provides a rapid, sensitive and straightforward way to measure cPDE activity in various sample types. In this assay, AMP produced by cPDE activity is metabolized by the enzyme mix, developer mix and converter mix to generate an intermediate compound, which reacts with a probe, yielding a fluorescent signal that can be measured at Ex/Em = 535/587 nm. This assay can detect cPDE activity as low as 0.1 µU per well.
Figure: cPDE activity in Rat lung and brain lysate. Rat tissue was prepared according to the described protocol. For activity determination, experiments were run in duplicates, with 0.9-3.6 µg protein (lung) or 0.1-0.4 µg protein (brain) loaded per well.
For detailed information on this assay kit, visit:
https://www.biovision.com/camp-phosphodiesterase-activity-assay-kit-fluorometric.html
